🔴 Structure Therapeutics is trading 4.06% down

Structure Therapeutics is trading 4.06% down at $33.64, with no verified company-specific announcement explaining the September 29 decline.

• A market roundup linked pressure on smaller obesity-drug companies to rising Treasury yields, but this is not independently confirmed as the direct cause of Structure Therapeutics’ move.
• Broad-index losses were modest. Reuters reported sharply weaker consumer confidence, while CNBC cited rising Treasury yields as weighing on equities.